Evidence map›Paper›PMID 34680932›Full record

ArticleGenes2021

Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese Patients.

Tomotaka Tanaka, Masafumi Ihara, Kazuki Fukuma, Haruko Yamamoto, Kazuo Washida, Shunsuke Kimura, Akiko Kada, Shigeki Miyata, Toshiyuki Miyata, Kazuyuki Nagatsuka

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tomotaka TanakaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.ORCID 0000-0002-6023-236X
Masafumi IharaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.ORCID 0000-0002-7102-4048
Kazuki FukumaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Haruko YamamotoCenter for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center, Suita, Osaka 564-8565, Japan.
Kazuo WashidaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Shunsuke KimuraDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Akiko KadaClinical Research and Development, National Cerebral and Cardiovascular Center, Suita, Osaka 564-8565, Japan.
Shigeki MiyataDepartment of Clinical Laboratory Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka 564-8565, Japan.
Toshiyuki MiyataDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka 564-8565, Japan.
Kazuyuki NagatsukaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
National Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genotypes of vitamin K epoxide reductase complex 1 (

Indexed as

Drug Dosage CalculationsGlomerular Filtration RatePharmacogenomic VariantsAgedAged, 80 and overAnticoagulantsCytochrome P-450 CYP2C9FemaleHumansKidneyMaleVitamin K Epoxide ReductasesWarfarinAnticoagulantsCYP2C9 protein, humanCytochrome P-450 CYP2C9Vitamin K Epoxide ReductasesVKORC1 protein, humanWarfarinCYP2C9dosing algorithmpharmacogeneticsrenal impairmentVKORC1warfarin

Identifiers

PMID34680932
PMCPMC8535514
OpenAlexW3204346544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.